These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 30933701)

  • 1. Metabolic syndrome among older adults with schizophrenia spectrum disorder: Prevalence and associated factors in a multicenter study.
    Abou Kassm S; Hoertel N; Naja W; McMahon K; Barrière S; Blumenstock Y; Portefaix C; Raucher-Chéné D; Béra-Potelle C; Cuervo-Lombard C; Guerin-Langlois C; Lemogne C; Peyre H; Kaladjian A; Limosin F;
    Psychiatry Res; 2019 May; 275():238-246. PubMed ID: 30933701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between clinical and psychosocial factors and metabolic and cardiovascular risk factors in overweight patients with schizophrenia spectrum disorders - Baseline and two-years findings from the CHANGE trial.
    Storch Jakobsen A; Speyer H; Nørgaard HCB; Hjorthøj C; Krogh J; Mors O; Nordentoft M
    Schizophr Res; 2018 Sep; 199():96-102. PubMed ID: 29501386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of abdominal obesity and its association with cardio metabolic risk factors among older adults in Ecuador.
    Orces CH; Montalvan M; Tettamanti D
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S727-S733. PubMed ID: 28549758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia.
    Hägg S; Lindblom Y; Mjörndal T; Adolfsson R
    Int Clin Psychopharmacol; 2006 Mar; 21(2):93-8. PubMed ID: 16421460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subsyndromal and syndromal depressive symptoms among older adults with schizophrenia spectrum disorder: Prevalence and associated factors in a multicenter study.
    Hoertel N; Jaffré C; Pascal de Raykeer R; McMahon K; Barrière S; Blumenstock Y; Portefaix C; Raucher-Chéné D; Béra-Potelle C; Cuervo-Lombard C; Chevance A; Guerin-Langlois C; Lemogne C; Airagnes G; Peyre H; Kaladjian A; Limosin F;
    J Affect Disord; 2019 May; 251():60-70. PubMed ID: 30904777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study.
    Birkenaes AB; Opjordsmoen S; Brunborg C; Engh JA; Jonsdottir H; Ringen PA; Simonsen C; Vaskinn A; Birkeland KI; Friis S; Sundet K; Andreassen OA
    J Clin Psychiatry; 2007 Jun; 68(6):917-23. PubMed ID: 17592917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications.
    Penninx BWJH; Lange SMM
    Dialogues Clin Neurosci; 2018 Mar; 20(1):63-73. PubMed ID: 29946213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of family history of hypertension on disease prevalence and associated metabolic risk factors among Sri Lankan adults.
    Ranasinghe P; Cooray DN; Jayawardena R; Katulanda P
    BMC Public Health; 2015 Jun; 15():576. PubMed ID: 26092387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study.
    Scuteri A; Najjar SS; Morrell CH; Lakatta EG;
    Diabetes Care; 2005 Apr; 28(4):882-7. PubMed ID: 15793190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical health in schizophrenia: a challenge for antipsychotic therapy.
    Heald A
    Eur Psychiatry; 2010 Jun; 25 Suppl 2():S6-11. PubMed ID: 20620888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort.
    Godin O; Leboyer M; Gaman A; Aouizerate B; Berna F; Brunel L; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Strat Y; Llorca PM; Misdrahi D; Rey R; Richieri R; Passerieux C; Schandrin A; Schürhoff F; Urbach M; Vidalhet P; Girerd N; Fond G;
    Schizophr Res; 2015 Oct; 168(1-2):388-94. PubMed ID: 26255568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of the metabolic syndrome in veterans with schizophrenia.
    Meyer J; Loh C; Leckband SG; Boyd JA; Wirshing WC; Pierre JM; Wirshing D
    J Psychiatr Pract; 2006 Jan; 12(1):5-10. PubMed ID: 16432440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance, metabolic syndrome, and lipids in African women.
    Young EE; Okafor CN; Iroezindu MO; Agbalu IS
    Niger J Clin Pract; 2016; 19(6):793-798. PubMed ID: 27811453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the prevalence of metabolic syndrome and its components in South Korea: Findings from the Korean National Health Insurance Service Database (2009-2013).
    Lee SE; Han K; Kang YM; Kim SO; Cho YK; Ko KS; Park JY; Lee KU; Koh EH;
    PLoS One; 2018; 13(3):e0194490. PubMed ID: 29566051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discordance of metabolic syndrome and abdominal obesity prevalence according to different criteria in Andean highlanders: A community-based study.
    Herrera-Enriquez K; Narvaez-Guerra O
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S359-S364. PubMed ID: 28284909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prevalence of Metabolic Syndrome in Alcohol Use Disorders: A Systematic Review and Meta-analysis.
    Vancampfort D; Hallgren M; Mugisha J; De Hert M; Probst M; Monsieur D; Stubbs B
    Alcohol Alcohol; 2016 Sep; 51(5):515-21. PubMed ID: 27337988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Health Status and Metabolic Syndrome in Adults Living in a Transition European Country: Findings from a Population-Based Study.
    Stojisavljević D; Janković J; Erić M; Marinković J; Janković S
    J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):568-574. PubMed ID: 29097061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Syndrome and Cardiovascular Risk in People Treated with Long-Acting Injectable Antipsychotics.
    Sanchez-Martinez V; Romero-Rubio D; Abad-Perez MJ; Descalzo-Cabades MA; Alonso-Gutierrez S; Salazar-Fraile J; Montagud V; Facila L
    Endocr Metab Immune Disord Drug Targets; 2018; 18(4):379-387. PubMed ID: 29165095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.